Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Market Cap
The (JAN) share price is expected to decrease by NAN% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered JAN. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for JAN is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedJAN 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on JAN. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of JAN.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
In 2023, JAN generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that JAN's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Fri, 12 Jul 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - JanOne Inc. will rebrand as ALT5 Sigma Corporation on July 15, 2024, with a new Nasdaq ticker symbol "ALTS," replacing "JAN."
Why It Matters - The rebranding of JanOne Inc. to ALT5 Sigma Corporation and the ticker change to ALTS may indicate a strategic shift, potentially affecting investor perception and stock performance.
Wed, 10 Jul 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - JanOne Inc. (Nasdaq: JAN) will conduct a strategic review of its biotech assets, focusing on ALT5 Sigma. The company plans to change its name and stock symbol to align with this strategy.
Why It Matters - The strategic review and focus on ALT5 Sigma signal a shift that could unlock value from biotech assets, potentially enhancing shareholder returns and attracting investor interest.
Mon, 08 Jul 2024
Sentiment - NEGATIVE
Source - InvestorPlace
Summary - Investors should assess their market positioning, particularly in fintech stocks, as AI has driven significant market expansion, with 10 S&P 500 stocks now representing 34% of the index.
Why It Matters - Market concentration in the S&P 500 indicates high risk in fintech stocks. AI-driven growth may lead to volatility, prompting investors to reassess their positions and potential for losses.
Tue, 25 Jun 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - JanOne Inc. (Nasdaq: JAN) announced the launch of a prepaid VISA®️ Card by its subsidiary ALT5 Sigma, enhancing its ALT5 Settlement Platform and expanding its fintech offerings in the crypto space.
Why It Matters - The launch of ALT5's prepaid VISA®️ Card enhances JanOne Inc.'s fintech capabilities, potentially increasing revenue streams and market competitiveness in the growing digital finance sector.
Wed, 26 Jun 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - JanOne Inc. has appointed Vay Tham as Chief Revenue Officer and President of its subsidiary ALT5 Sigma, Inc., enhancing its leadership in healthcare and fintech sectors.
Why It Matters - The appointment of a new Chief Revenue Officer may signal a strategic shift or growth potential for JanOne Inc., impacting revenue forecasts and investor confidence in the company's direction.
Thu, 13 Jun 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - JanOne Inc.'s subsidiary, ALT5 Sigma, reported transaction volume of $289 million for April and May 2024, a 91% increase from $151 million in the same months of 2023.
Why It Matters - JanOne Inc.'s significant 91% increase in transaction volume at ALT5 Sigma indicates strong growth in its fintech operations, potentially boosting investor confidence and stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
